Chalandon Y - Search Results

1

Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT.

Nabergoj M, Mauff K, Beelen D, Ganser A, Kröger N, Stölzel F, Finke J, Passweg J, Cornelissen J, Schub N, Veelken JH, Beguin Y, Wilson K, Zuckerman T, Hunault-Berger M, Lioure B, Porras RP, Turlure P, Kerre T, Koster L, Hayden PJ, Onida F, Scheid C, Chalandon Y, Robin M, Yakoub-Agha I. Nabergoj M, et al. Among authors: chalandon y. Bone Marrow Transplant. 2022 Jul;57(7):1072-1078. doi: 10.1038/s41409-022-01686-7. Epub 2022 Apr 22. Bone Marrow Transplant. 2022. PMID: 35459878 Free article.

2

Agrobacterium yellow group: bacteremia and possible septic arthritis following peripheral blood stem cell transplantation.

Chalandon Y, Roscoe DL, Nantel SH. Chalandon Y, et al. Bone Marrow Transplant. 2000 Jul;26(1):101-4. doi: 10.1038/sj.bmt.1702470. Bone Marrow Transplant. 2000. PMID: 10918412

3

Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.

Chalandon Y, Barnett MJ, Horsman DE, Conneally EA, Nantel SH, Nevill TJ, Nitta J, Shepherd JD, Sutherland HJ, Toze CL, Hogge DE. Chalandon Y, et al. Biol Blood Marrow Transplant. 2002;8(8):435-43. doi: 10.1053/bbmt.2002.v8.pm12234169. Biol Blood Marrow Transplant. 2002. PMID: 12234169 Free article.

4

Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation.

Chalandon Y, Roosnek E, Mermillod B, Newton A, Ozsahin H, Wacker P, Helg C, Chapuis B. Chalandon Y, et al. Biol Blood Marrow Transplant. 2004 May;10(5):347-54. doi: 10.1016/j.bbmt.2004.01.002. Biol Blood Marrow Transplant. 2004. PMID: 15111934 Free article. Clinical Trial.

5

Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients.

Kyle UG, Chalandon Y, Miralbell R, Karsegard VL, Hans D, Trombetti A, Rizzoli R, Helg C, Pichard C. Kyle UG, et al. Among authors: chalandon y. Bone Marrow Transplant. 2005 Jun;35(12):1171-7. doi: 10.1038/sj.bmt.1704996. Bone Marrow Transplant. 2005. PMID: 15880127

6

Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation.

Einsele H, Reusser P, Bornhäuser M, Kalhs P, Ehninger G, Hebart H, Chalandon Y, Kröger N, Hertenstein B, Rohde F. Einsele H, et al. Among authors: chalandon y. Blood. 2006 Apr 1;107(7):3002-8. doi: 10.1182/blood-2005-09-3786. Epub 2005 Dec 13. Blood. 2006. PMID: 16352807 Free article. Clinical Trial.

7

Can only partial T-cell depletion of the graft before hematopoietic stem cell transplantation mitigate graft-versus-host disease while preserving a graft-versus-leukemia reaction? A prospective phase II study.

Chalandon Y, Roosnek E, Mermillod B, Waelchli L, Helg C, Chapuis B. Chalandon Y, et al. Biol Blood Marrow Transplant. 2006 Jan;12(1):102-10. doi: 10.1016/j.bbmt.2005.09.010. Biol Blood Marrow Transplant. 2006. PMID: 16399574 Free article. Clinical Trial.

8

Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland.

Chalandon Y, Tiercy JM, Schanz U, Gungor T, Seger R, Halter J, Helg C, Chapuis B, Gratwohl A, Tichelli A, Nicoloso de Faveri G, Roosnek E, Passweg JR; Swiss Transplant Working Group for Blood and Marrow Transplantation (STABMT); Swiss National Donor Registry. Chalandon Y, et al. Bone Marrow Transplant. 2006 May;37(10):909-16. doi: 10.1038/sj.bmt.1705353. Bone Marrow Transplant. 2006. PMID: 16565739

9

Association of TNFd and IL-10 polymorphisms with mortality in unrelated hematopoietic stem cell transplantation.

Bettens F, Passweg J, Gratwohl A, Chalandon Y, Helg C, Chapuis B, Schanz U, Libura J, Roosnek E, Tiercy JM. Bettens F, et al. Among authors: chalandon y. Transplantation. 2006 May 15;81(9):1261-7. doi: 10.1097/01.tp.0000208591.70229.53. Transplantation. 2006. PMID: 16699452

10

The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable.

Tiercy JM, Nicoloso G, Passweg J, Schanz U, Seger R, Chalandon Y, Heim D, Güngör T, Schneider P, Schwabe R, Gratwohl A. Tiercy JM, et al. Among authors: chalandon y. Bone Marrow Transplant. 2007 Sep;40(6):515-22. doi: 10.1038/sj.bmt.1705787. Epub 2007 Jul 23. Bone Marrow Transplant. 2007. PMID: 17646842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

317 results

Search Page